0001209191-21-068385.txt : 20211207
0001209191-21-068385.hdr.sgml : 20211207
20211207174141
ACCESSION NUMBER: 0001209191-21-068385
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211130
FILED AS OF DATE: 20211207
DATE AS OF CHANGE: 20211207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Scott Andrew
CENTRAL INDEX KEY: 0001614975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39787
FILM NUMBER: 211477004
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioAtla, Inc.
CENTRAL INDEX KEY: 0001826892
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851922320
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11085 TORREYANA ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-558-0708
MAIL ADDRESS:
STREET 1: 11085 TORREYANA ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-30
0
0001826892
BioAtla, Inc.
BCAB
0001614975
Smith Scott Andrew
C/O BIOATLA, INC. 11085 TORREYANA ROAD
SAN DIEGO
CA
92121
1
1
0
0
President
Common Stock
2021-11-30
2021-12-03
4
S
0
194
23.997
D
349552
D
Common Stock
2021-11-30
2021-12-03
4
S
0
210
24.676
D
349342
D
Common Stock
2021-11-30
2021-12-03
4
S
0
74
25.379
D
349268
D
Common Stock
2021-12-01
2021-12-06
4
S
0
202
22.186
D
349066
D
Common Stock
2021-12-01
2021-12-06
4
S
0
350
23.266
D
348716
D
Common Stock
2021-12-01
2021-12-06
4
S
0
76
24.224
D
348640
D
Common Stock
2021-12-02
2021-12-06
4
S
0
2925
21.741
D
345715
D
Common Stock
2021-12-02
2021-12-06
4
S
0
59
22.471
D
345656
D
Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs.
The range of prices for the shares of Common Stock is from $23.33 to $24.32. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
The range of prices for the shares of Common Stock is from $24.33 to $25.25. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
The range of prices for the shares of Common Stock is from $25.30 to $25.38. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
The range of prices for the shares of Common Stock is from $21.79 to $22.73. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
The range of prices for the shares of Common Stock is from $22.79 to $23.77. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
The range of prices for the shares of Common Stock is from $23.80 to $24.68. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
The range of prices for the shares of Common Stock is from $21.40 to $22.37. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
The range of prices for the shares of Common Stock is from $22.40 to $22.51. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
/s/ Christian Vasquez, as Attorney-in-Fact for Scott A. Smith
2021-12-07